The National Institute on Drug Abuse HIV/AIDS Pilot Proteomics Centers (P20)

The summary for the The National Institute on Drug Abuse HIV/AIDS Pilot Proteomics Centers (P20) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
The National Institute on Drug Abuse HIV/AIDS Pilot Proteomics Centers (P20): -This Funding Opportunity Announcement (FOA) issued by NIDA, National Institutes of Health, solicits applications to establish Pilot Proteomics Centers that will address the complex biological mechanisms of interactions among drugs of abuse and HIV pathogenesis, their treatments, and host responses. The centers will use proteomics technologies and other related technologies (i.e., gene expression profiling) to look for protein changes and molecular signatures of disease progression of HIV/AIDS in combination with substance abuse/addiction, HIV treatment, and/or treatments for substance abuse. These proteomics centers are expected to help identify mechanisms related to susceptibility to and progression of HIV infection, viral replication, and viral evolution, particularly related to neuroAIDS. The use of advanced tools to better understand the molecular and cellular consequences of HIV-1 infection and substance abuse in the era of HAART will likely lead to the identification of new biomarkers for disease progression and new avenues for clinical research and interventions. -The total amount to be awarded is $2,000,000 to support one or two centers using the P20 mechanism. Individual awards will be limited to $700,000 direct costs for each of three years. -Eligible organizations include: Public/State Controlled Institution of Higher Education, Private Institution of Higher Education, Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education), Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education), Small Business, For-Profit Organization (Other than Small Business), State Government, U.S. Territory or Possession, Indian/Native American Tribal Government (Federally Recognized), Indian/Native American Tribal Government (Other than Federally Recognized), Indian/Native American Tribally Designated Organization.
Federal Grant Title: The National Institute on Drug Abuse HIV/AIDS Pilot Proteomics Centers (P20)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-08-010
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Mar 27, 2008
Posted Date: Dec 17, 2007
Creation Date: Dec 17, 2007
Archive Date: Apr 27, 2008
Total Program Funding: $2,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
County governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Special district governments For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Small businesses Native American tribal organizations (other than Federally recognized tribal governments) State governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities City or township governments
Additional Information on Eligibility
Foreign institutions are not eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...
Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...
Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com